AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. (ANTX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 138 transactions totaling $68.8M, demonstrating a bullish sentiment with $37.7M in net insider flow. The most recent transaction on Jan 12, 2026 involved a transaction of 11,560 shares valued at $0.
ANTX Insider Activity Summary
Who Is Buying ANTX Stock?
No significant insider buying has been recorded for ANTX in the recent period.
Who Is Selling ANTX Stock?
No significant insider selling has been recorded for ANTX in the recent period.
Is AN2 Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ANTX is bullish with an Insider Alignment Score of 77/100 and a net flow of $37.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ANTX Frequently Asked Questions
Understanding ANTX Insider Activity
Insider trading at AN2 Therapeutics, Inc. (ANTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading ANTX stock, having executed 138 transactions in the past 90 days. The most active insider is Peter Kolchinsky (Executive), who has made 4 transactions totaling $25.0M.
Related Tools
Track AN2 Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ANTX file new Form 4 transactions